Key Development
Radiant Parenterals Limited, a wholly owned subsidiary of Rekvina Laboratories Limited, will temporarily shut down its manufacturing facility effective October 28, 2026. The purpose of the shutdown is to undertake renovation and upgradation works and install an additional vial manufacturing line.
Duration and Operations
The facility shutdown begins on October 28, 2026. The company will update the stock exchanges once operations at the facility have resumed. No specific end date for the shutdown or resumption of operations is provided in the disclosure.
Project Management
The company will take all necessary measures to ensure timely completion of the renovation, upgradation, and installation project. The company commits to keeping the stock exchanges informed of any material developments regarding this project in accordance with applicable regulatory requirements.
Financial Impact
Financial impact not quantified in the disclosure.